Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05655156

OrthoPureXT Multiligament PMCF Study

Led by Tissue Regenix Ltd · Updated on 2025-04-15

28

Participants Needed

1

Research Sites

87 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To monitor residual risks in the post-market phase and to ensure continued clinical evaluation of the device safety and performance to ensure that no new or unexpected risks arise when used during multi-ligament knee reconstructions.

CONDITIONS

Official Title

OrthoPureXT Multiligament PMCF Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male and female patients aged 18 years old or above.
  • Adults suffering with multiple knee ligament injuries.
  • Ability to communicate meaningfully with investigative staff, competence to give written informed consent; and willingness and ability to comply with entire study procedures including rehabilitation protocol.
Not Eligible

You will not qualify if you...

  • Unable to give consent.
  • Conflicting variables such as open trauma, neurovascular emergencies, compartment syndrome, or life threatening injury.
  • Physical barriers including associated fractures requiring external fixators, severe local injuries, or injuries to other body parts that require high levels of care.
  • Considered a poor candidate for surgery by the investigator.
  • If female and of child-bearing potential, positive pregnancy test or intention to become pregnant within 12 months.
  • Contraindications including signs of infection within 24 hours prior to surgery.
  • Known allergy, hypersensitivity, or religious objection to implanted porcine material.
  • Unable or unwilling to follow post-operative care and rehabilitation program.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Royal Stoke University Hospital

Stoke-on-Trent, United Kingdom, ST4 6QG

Actively Recruiting

Loading map...

Research Team

A

Anna Kaniewska

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here